SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-015297
Filing Date
2020-06-04
Accepted
2020-06-04 19:11:08
Documents
2
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3978
2 EX-24 DOCUMENT attachment1.htm EX-24 4379
  Complete submission text file 0000899243-20-015297.txt   9770
Mailing Address 888 7TH AVENUE 12TH FLOOR NEW YORK NY 10106
Business Address
AGUIAR ERIC (Reporting) CIK: 0001262325 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 20944084

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations